FDA-FY22-SS-1258732.pdf

FDA- FY22-SS-1258732

QIAcuity One 5plex Platform System FU2 with Installation, Training, plus Two (2) Years of Preventative Maintenance with a 2-Business Day Response Time.

The U.S. Food and Drug Administration (FDA) hereby issue this notice of intent to award a sole source firm fixed price purchase order to Government Scientific Source, Inc. 12351 Sunrise Valley Drive, Reston, Virginia, 20191 for a QIAcuity One 5plex Platform System FU2 includes with installation, training, with two (2) years of preventative maintenance with a 2-business day response time.

This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(1) to use simplified procedures for commercial acquisitions. The North American Industry Classification System Code is 334516 - Analytical Laboratory Instrument Manufacturing.

Only one award will be made as a result of this notice. This will be a firm fixed price type purchase order. Period of performance shall be one (1) year from date of award.

THIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS; no solicitation document is available and telephone request will not be accepted. The proposed contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under authority of FAR 13.106-1(b) (1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive proposals. However, all proposals received within 7 days after date of publication of this notice will be considered by the government. The capability statement must be received via email by on or before 10:00 AM, ET on August 1, 2022. All questions must be submitted in writing and can be emailed to Linda Troutman, Contract Specialist at Linda.Troutman@fda.hhs.gov, in the subject line of the email please reference (FDA-FY22-SS- 1258732). A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose, of determining whether to conduct a competitive procurement.

mailto:Linda.Troutman@fda.hhs.gov

This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(1) to use simplified procedures for commercial acquisitions. The North American Industry Classificati...